Table 3.
Additional Treatments for MAS Administered In Hospital
| Medications | % |
|---|---|
| IV steroids | 47.8 |
| Intravenous Immunoglobulin | 17.4 |
| Cyclophosphamide | 13.0 |
| Rituximab | 8.7 |
| Cyclosporine | 8.7 |
| Anakinra | 8.7 |
| Etoposide | 8.7 |
| Allogeneic BMT | 8.7 |
| Mycophenolate mofetil | 8.7 |
| Hydroxychloroquine | 8.7 |
| Alemtuzumab | 4.3 |